Hyderabad-based Natco Pharma is expected to expand its active pharmaceutical ingredients (APIs) and API Intermediates manufacturing facility in Telangana's Rangareddy district, with a total estimated project cost of Rs 480.31 crore. The project has recently received environmental clearance from the Union government.
According to the approval by the Union Ministry of Environment, Forest and Climate Change, the expansion will be taking place in the existing land area, with an estimated project cost of Rs 480.31 crore, including existing investment of around Rs 314.31 crore.
It added that the facility has been manufacturing three products and the proposal is to build capacities for